DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @Lin_ling_88 | 10 |
| @Gambiste1 | 4 |
| @SelfThink4 | 2 |
| @ThisLincolnian | 2 |
| @ConsumerFeed | 2 |
Recent Tweets for GNCA
 |
@st_kinne $GNCA- I’m stalking this one as well. July 15th 2019, 3:07pm |
 |
@Gambiste1 RT @TekATL3: $GNCA may share, before the pop to 11 https://t.co/DBo5ugGi4j July 13th 2019, 2:07am |
 |
@TekATL3 $GNCA may share, before the pop to 11 https://t.co/DBo5ugGi4j July 12th 2019, 11:07pm |
 |
@AmericanBanking Genocea Biosciences Inc $GNCA Short Interest Up 25.4% in June https://t.co/759cc4ZhSB #stocks July 12th 2019, 8:07pm |
 |
@ThisLincolnian Genocea Biosciences Inc $GNCA Short Interest Up 25.4% in June https://t.co/iq6oFrC1K1 July 12th 2019, 8:07pm |
 |
@SelfThink4 $GNCA no support yet. ? In a serious Downtrend now. https://t.co/yy2CXofMGO July 12th 2019, 3:07pm |
 |
@r_holliday2 $GNCA Added more this morning. It's cheap. It's all about playing the probabilities of success, and I like their ch… https://t.co/894oMIBUzv July 12th 2019, 1:07pm |
|
@ThisLincolnian Genocea Biosciences $GNCA Now Covered by Stifel Nicolaus https://t.co/LgvWUaBKWj July 12th 2019, 8:07am |
 |
@ConsumerFeed Genocea Biosciences $GNCA Now Covered by Stifel Nicolaus https://t.co/SfdrsLTXql July 12th 2019, 8:07am |
|
@SelfThink4 $GNCA ugly breakdown. $3.50 level is possibly next. https://t.co/WinPlIA3o5 July 11th 2019, 8:07pm |
 |
@Lin_ling_88 RT @OneMdcn: $GNCA New July Presentation Slide Deck https://t.co/Mc5phTevjW July 11th 2019, 8:07pm |
 |
@bbnsnews Genocea Biosciences $GNCA Earns Buy Rating from Analysts at Stifel Nicolaus https://t.co/LxS5wSQZGn July 11th 2019, 8:07pm |
|
@OneMdcn $GNCA New July Presentation Slide Deck https://t.co/Mc5phTevjW July 11th 2019, 11:07am |
 |
@StockflareUS $GNCA: The recommendation for Genocea Biosciences Inc has been upgraded to Strong Buy. (https://t.co/6vJYoItWZ6) July 9th 2019, 6:07am |
|
@Gambiste1 RT @ez_scans: $GNCA (( l4_lbbb ))=lower bband bounce July 8th 2019, 2:07pm |
 |
@firsttomarkets Genocea Biosciences Inc Reiterated Rating by Stifel Nicolaus (Ranked 34th) to Buy with $13PT $GNCA #GNCA https://t.co/25mq3Ybhmi July 8th 2019, 10:07am |
 |
@TopStockAlerts1 $GNCA Keep an eye on it for today! https://t.co/ZKx6HyHoXo July 8th 2019, 9:07am |
|
@Lin_ling_88 Dana Farber article also bodes well for $GNCA: - GEN009 + combo study w/checkpoint inhibitor (5 target indicatio… https://t.co/P3uv8obabp July 8th 2019, 8:07am |
|
@Gambiste1 RT @Lin_ling_88: The collaborative program between $IOVA and $GNCA on GEN-011 to aim at optimized neoAg-based cell therapy for solid & heme… July 8th 2019, 5:07am |
|
@Lin_ling_88 The collaborative program between $IOVA and $GNCA on GEN-011 to aim at optimized neoAg-based cell therapy for solid… https://t.co/TWQuyWJIHS July 8th 2019, 1:07am |
|
@dakotafinancial Analysts Anticipate Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/tcuB1HV9NF July 7th 2019, 8:07pm |
|
@r_holliday2 RT @Lin_ling_88: $GNCA to give oral presentation at upcoming “Targeted Therapies - Immuno-Oncology Summit” 2019, August 8-9, Boston 8/8,… July 7th 2019, 7:07pm |
|
@Gambiste1 RT @Lin_ling_88: $GNCA oral presentation (continued) Genocea is applying ATLAS in its two lead programs: GEN-009, a neoantigen vaccine cu… July 7th 2019, 6:07pm |
|
@Lin_ling_88 $GNCA oral presentation (continued) Genocea is applying ATLAS in its two lead programs: GEN-009, a neoantigen vac… https://t.co/WUQwtyHq8a July 7th 2019, 6:07pm |
|
@Lin_ling_88 $GNCA presentation (continued) Excluding inhibitory peptides that may suppress tumor immunity, accelerate tumor pr… https://t.co/d9TleQz1du July 7th 2019, 6:07pm |
|
@Lin_ling_88 $GNCA: brief description of presentation att the I-O Summit: Genocea’s ATLAST platform is a powerful tool that sc… https://t.co/fzIpERd2kx July 7th 2019, 6:07pm |
|
@Lin_ling_88 $GNCA to give oral presentation at upcoming “Targeted Therapies - Immuno-Oncology Summit” 2019, August 8-9, Boston… https://t.co/PfyFxvpbfu July 7th 2019, 6:07pm |
 |
@WatchlistN Genocea Biosciences $GNCA Raised to “Buy” at Zacks Investment Research https://t.co/tt9HZk5vXO July 7th 2019, 5:07am |
 |
@macondailynews Genocea Biosciences $GNCA Raised to “Buy” at Zacks Investment Research https://t.co/PQROmx6yUr July 6th 2019, 8:07am |
|
@macondailynews Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/t8uR5gFihl July 6th 2019, 6:07am |
 |
@TickerReport Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/Cutd3tRmJi July 6th 2019, 6:07am |
 |
@TheMarketsDaily Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/z9b3TuyFRR July 6th 2019, 6:07am |
 |
@midetimes Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/jdb7CLg674 #stocks July 5th 2019, 7:07pm |
 |
@dailymailtimes Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/MO0BKleVmo #investing July 5th 2019, 7:07pm |
 |
@dailypoliticaln Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/HBNJMJKCIx July 5th 2019, 7:07pm |
 |
@ZolmaxNews Zacks: Analysts Anticipate Genocea Biosciences Inc $GNCA Will Announce Earnings of -$0.78 Per Share https://t.co/ZwmUS8HuyM July 5th 2019, 7:07pm |
 |
@WKRBNews Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/MyEYKh1GO7 #markets July 5th 2019, 7:07pm |
 |
@ProTradersNews $GNCA: What Type Of Shareholder Owns Genocea Biosciences, Inc.’s …: https://t.co/cmBNs6TeMs July 5th 2019, 3:07pm |
 |
@ez_scans $GNCA (( l4_lbbb ))=lower bband bounce July 5th 2019, 9:07am |
|
@WKRBNews Genocea Biosciences $GNCA Cut to “Sell” at ValuEngine https://t.co/Y9dB7bZ1E0 #markets July 5th 2019, 9:07am |
|
@OneMdcn RT @Lin_ling_88: @thejadedtrader $GNCA: totally agreed. I am not aware of any cases or precedent where (powerfully) elicited CD8+ T cell re… July 5th 2019, 6:07am |
|
@TickerReport Zacks Investment Research Upgrades Genocea Biosciences $GNCA to Buy https://t.co/p5qfWDPQdO July 5th 2019, 4:07am |
|
@ConsumerFeed Zacks Investment Research Upgrades Genocea Biosciences $GNCA to Buy https://t.co/LEPNqIAnLN July 5th 2019, 4:07am |
|
@Lin_ling_88 @thejadedtrader $GNCA: totally agreed. I am not aware of any cases or precedent where (powerfully) elicited CD8+ T… https://t.co/QYsNR5UYEd July 4th 2019, 11:07pm |
|
@Lin_ling_88 Short Interest in $GNCA Declines By 87.2%. Also.... ??Major shareholder Peter Sonsini bought 2,857,142 shares of G… https://t.co/5ok2dt9XXC July 4th 2019, 6:07pm |
 |
@thejadedtrader $GNCA still the only screen capable of detecting inhibitory neoantigens. Huge value for solid tumor ACT’s that targ… https://t.co/KuwgQpfoeR July 4th 2019, 4:07pm |
|
@Lin_ling_88 @rogerthat191 No way you can compare CAPR with $GNCA...orders of magnitude in difference. July 4th 2019, 12:07pm |
|
@dakotafinancial Genocea Biosciences $GNCA Stock Rating Lowered by ValuEngine https://t.co/mZvixjEO2A July 4th 2019, 8:07am |
|
@TopStockAlerts1 $GNCA setting up! https://t.co/ZKx6HyHoXo July 3rd 2019, 12:07am |
 |
@ChartMill $GNCA: Comparing the growth rate of the last 5 years to the rate of the upcoming 2 years, we see that the growt ...… https://t.co/TPHG8sedje July 2nd 2019, 11:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.